Loading...
Trifluoperazine versus placebo for schizophrenia
Mansi, Kamel Haynes, Euan Adams, Clive E.
Mansi, Kamel
Haynes, Euan
Adams, Clive E.
Abstract
This is the prodrug tocol for a review and there is no abstract. The objectives are as follows: To determine the absolute effects of trifluoperazine for schizophrenia and schizophrenia-like illnesses when compared with placebo.
MIDER Authors
Citations
Altmetric:
Date
2012
Type
Article
Subject
Drug therapy, Schizophrenia
Collections
Citation
Koch, K., Mansi, K., Haynes, E. & Adams, C. E. (2012). Trifluoperazine versus placebo for schizophrenia. Cochrane Database of Systematic Reviews, (11).
Journal / Source Title
DOI
PMID
Publisher
Publisher’s URL
Publisher’s statement
Files
Loading...
Koch 2012 1-11.pdf
Adobe PDF, 179.97 KB